Killer immunoglobulin-like receptor (KIR)s have previously shown significant differences in NK cells of CFS/ME patients, although these had not been examined in CD4+T or CD8+T cells in CFS/ME patients [5, 7]. The gene discussed is KIR3DL1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.